Normalina Sandora

Dr. Normalina Sandora


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Academia Biology
Verified
Journal Article
Open access
PDF file
NSNormalina Sandora
Normalina Sandora
BWBudi Wiweko
Budi Wiweko
RMRaden Muharam
Raden Muharam
AHAchmad Kemal Harzif
Achmad Kemal Harzif
NSNormalina Sandora
Normalina Sandora
AHAndon Hestiantoro
Andon Hestiantoro
Background: Endometrium disorders cause significant failure in fertility. Our study aimed to investigate the cellular, histological, and molecular properties of patients with thin endometrium compared to healthy endometrium without pathological conditions (n = 6). Methods: This study was a randomized control (n = 6) in which samples of thin endometrium were obtained from IVF patients enrolled in the IVF clinic in the National Hospital Ciptomangunkusumo, Jakarta, Indonesia, from 2018 to 2019. The typical samples were taken from patients who underwent tubectomy with no pathological findings in the endometrium. Endometrial cells were isolated using an enzymatic method transported in medium, PCR samples were used in an RNA solution, and histology samples were stored in neutral-buffered formalin 10% (v/v). Results: The number of cells, presented as density of cells mg−1 wet weight during endometrial biopsy, was about 10,190 cells mg−1 wet weight in the healthy-endometrium group, while the thin-endometrium group had 3305 cells mg−1 wet weight. A flow cytometry analysis of the endometrial in the healthy group showed all panels were significantly higher compared to the thin group: BCRP1/Breast Cancer-Resistant Protein (74.85 ± 15.63% vs. 15.58 ± 7.19%), ICAM-1/Intercellular Adhesion Molecule or CD54 (35.76 ± 6.23% vs. 7.24 ± 1.65%), PECAM/platelet endothelial cell adhesion molecule-1 or CD31 (29.42 ± 2.16% vs. 4.19 ± 2.03%), and cKit/type III receptor tyrosine kinase or CD117 (27.29 ± 1.93% vs. 5.32 ± 2.38%). The exception was SUSD-2/Sushi Domain Containing Protein-2, although these results were insignificant (1.33 ± 0.39% vs. 0.26 ± 0.39%, respectively) (mean ± 95% C.l). Endometrial receptivity, indicated by HOXA10/Homeobox protein-10, LIF/Leukemia inhibitory factor, SPP1/osteopontin, and VEGF/Vascular Endothelial Growth Factor, was significantly higher in the healthy group compared to the thin group. Immunohistochemical labelling showed that E-cadherin, estrogen/ER-α, and progesterone receptors/PR were found in healthy-endometrium patients while they were less expressed among thin-endometrium patients. Conclusions: Patients with healthy endometrium had significantly higher cell numbers per mg, significantly higher endometrial and endothelial cells, and expressed higher receptivity genes than patients with thin endometrium, although the SUSD-2-positive cells showed no difference.